References
- Shefner JM, Cudkowicz ME, Schoenfeld D, Conrad T, Taft J, Chilton M, et al. A clinical trial of creatine in ALS. Neurology. 2004; 63: 1656–61
- Strong M, Rosenfeld J. Amyotrophic lateral sclerosis: a review of current concepts. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003; 4: 136–43
- Hervias I, Beal MF, Manfredi G. Mitochondrial dysfunction and amyotrophic lateral sclerosis (see comment). Muscle & Nerve. 2006; 33: 598–608
- Ellerby L, Cabelli DE, Graden JA, Valentine JS. Cooper-zinc superoxide dismutase: why not pH-dependent?. J Am Chem Soc. 1996; 118: 6556–61
- Harris RC, Soderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clinical Science. 1992; 83: 367–74
- Tarnopolsky MA, Roy BD, MacDonald JR. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies (see comments). Muscle & Nerve. 1997; 20: 1502–9
- Walker JB. Creatine: biosynthesis, regulation, and function. (Review). Advances in Enzymology & Related Areas of Molecular Biology. 1979; 50: 177–242
- Lykken GI, Jacob RA, Munoz JM, Sandstead HH. A mathematical model of creatine metabolism in normal males: comparison between theory and experiment. American Journal of Clinical Nutrition. 1980; 33: 2674–85
- Casey A, Greenhaff PL. Does dietary creatine supplementation play a role in skeletal muscle metabolism and performance?. American Journal of Clinical Nutrition. 2000; 72(Suppl 2)S607–17
- Greenhaff PL, Bodin K, Soderlund K, Hultman E. Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. American Journal of Physiology. 1994; 266: E725–30
- Greenhaff PL. Creatine supplementation: recent developments (editorial). British Journal of Sports Medicine 1996; 30: 276–7
- O'Gorman E, Beutner G, Wallimann T, Brdiczka D. Differential effects of creatine depletion on the regulation of enzyme activities and on creatine-stimulated mitochondrial respiration in skeletal muscle, heart, and brain. Biochimica et Biophysica Acta. 1996; 1276: 161–70
- Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Medicine. 1999; 5: 347–50
- Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Florence J, et al. Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology. 1989; 39: 475–81
- Tarnopolsky M, Martin J. Creatine monohydrate increases strength in patients with neuromuscular disease (see comments). Neurology. 1999; 52: 854–7
- Rosenfeld J. Creatine monohydrate in amyotrophic lateral sclerosis: preliminary results. In: American Academy of Neurology Annual Meeting; 2001.
- Jan Groeneveld G, Veldink JH, van der Tweel I, Kalmijn S, Beijer C, de Visser M, et al. A randomized sequential trial of creatine in amyotrophic lateral sclerosis. Annals of Neurology. 2003; 53: 437–45
- World Federation of Neurology Research Group on Motor Neuron Diseases (1998) . El Escorial Revisited: Revised Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. In:. B Brooks. ALS Consensus Conference; 1998; Airlie House, Warrenton, Virginia: World Federation of Neurology; .
- Sanjak M, Konopacki R, Capasso R, Roelke KA, Peper SM, Houdek AM, et al. Dissociation between mechanical and myoelectrical manifestation of muscle fatigue in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5: 26–32
- Sanjak M, Brinkmann J, Belden DS, Roelke K, Waclawik A, Neville HE, et al. Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis. Journal of the Neurological Sciences. 2001; 191: 55–9
- Diggle P, Liang K, Zeger S. Analysis of Longitudinal Data. Oxford University Press, New York 1994
- Meinert C. Clinical Trials, Design, Conduct, and Analysis. Oxford University Press, New York 1986
- Brown H, Prescott R. Applied Mixed Models in Medicine: Statistics in Practice. John Wiley & Sons, New York 2000